Crystal Adam 4
4 · Tango Therapeutics, Inc. · Filed Mar 2, 2023
Insider Transaction Report
Form 4
Crystal Adam
President, R&D
Transactions
- Award
Common Stock
2023-03-01+81,250→ 81,250 total - Award
Stock Option (Right to Buy)
2023-03-01+487,500→ 487,500 totalExercise: $5.20Exp: 2033-03-01→ Common Stock (487,500 underlying)
Footnotes (2)
- [F1]These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 1/3 on February 5, 2024, 1/3 on February 3, 2025 and 1/3 on February 2, 2026 subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
- [F2]This option shall vest and become exercisable over a four-year period, at a rate of 25% on February 27, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter.